Form 8-K Genufood Energy Enzymes For: Aug 16

August 16, 2022 10:54 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
0001510518 false 0001510518 2022-08-16 2022-08-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares





Washington, D.C. 20549






Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): August 16, 2022



(Exact name of registrant as specified in charter)


Nevada   000-56112   68-0681158
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)


1108 S. Baldwin Avenue, Suite 107

Arcadia, California

(Address of principal executive offices)   (Zip Code)


(855) 707-2077

Registrant’s telephone number


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)


  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))


  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))


  Securities registered pursuant to Section 12(b) of the Act: None


Title of each class   Trading Symbol(s)   Name of each exchange on which registered


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  






Item 8.01 Other Events.


As previously reported on a Current Report on Form 8-K that was filed with the Securities and Exchange Commission on August 4, 2022, the Board of Genufood Energy Enzymes Corp. (the “Company”) unanimously approved to expand the Company’s business in the area of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such industry.


On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless technology and carbon-neutral vehicle-charging infrastructure.







Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: August 16, 2022 By: /s/ David Tang
    David Tang
    Chief Executive Officer




Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings